Skip to main content
Caplight Logo









RNA NanoBiotics, Inc.

RNA NanoBiotics, Inc.

Private
Columbus, OhioHealthcare & Life Scienceshttps://rna-nano.com/

Last Round

VC Round

Jan 1, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

RNA NanoBiotics, Inc. is a biotechnology company that develops nanoparticle-based drug delivery systems for targeted cancer therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanoparticle deliveryRNA therapeuticsdrug delivery platformbiotechnology R&Dnucleic acid medicinemRNA vaccinesgene therapydrug delivery techbiotech licensingpreclinical researchnanomedicinedrug delivery systemsbiopharma partnershiptargeted delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RNA NanoBiotics, Inc. Comparables

Compare RNA NanoBiotics, Inc. with similar companies based on industry and business-model similarity.

RNA NanoBiotics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoVation Therapeutics
84%
Entos Pharmaceuticals
82%
Genevant Sciences
80%

RNA NanoBiotics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 1, 2025

Key People

Founding team and executive leadership

James Carroll

President and Chief Executive Officer

Executive Team

RNA NanoBiotics, Inc. Investors

Notable investors and investment history

RNA NanoBiotics, Inc. investors
InvestorRounds
Symbiotic VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 4120% MoM, from 25 to 1.1K.

  • Apr 6, 2026

    Monthly visitors increased 1204% from 25 to 326.

RNA NanoBiotics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RNA NanoBiotics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RNA NanoBiotics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersColumbus, Ohio
Employee Range3
Year Founded2024
Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?